focused

on the future

Apart from medicines that proof their value on the market, Synthon always has products under development. You can find these in the table below. The CTD dossiers, meant for the registration of these new products, are expected to be filed within the next three years. It regards registration in one or more of the following areas: Europe, the United States and Australia.

therapeutic field

molecules

ctd-dossiers

Allergy and Respiratory Diseases 2 4
Cardiovascular/ Metabolic and Endocrine Diseases 13 18
Central nervous system 19 37
Genitourinary disorders 4 7
Women's health 1 2
Oncology 16 28
Osteoporosis 3 5
Pain treatment 2 4
totaal 60 105
Home
Disclaimer
Nederlands
Český
Español
Русский